FEBRUARY 19, 2012
Notice
  • Sorry! That page cannot be found.

ASCO 2008 Annual Meeting - Phase II Trial of Meloxicam, a COX-2 Inhibitor, and Interferon Alfa in Patients with Metastatic Renal Cell Carcinoma

E-mail Print

Abstract No.: 16073
Citation: J Clin Oncol 26: 2008 (May 20 suppl; abstr 16073)
Author(s): S. F. Slovin, R. J. Motzer, M. Jefferson, P. Gregor, J. D. Wolchok, M. Czarny, T. Curley, A. Delacruz, H. I. Scher




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |